Gevo Inc SEC Filings

Form 144 filed for Gevo, Inc. (GEVO) reporting a proposed sale of 1,683 shares of Common Stock through Stifel Nicolaus & Company, with an aggregate market value of $2,742.00 and an approximate sale date of 09/04/2025. The securities were acquired as Restricted Stock Units on 09/03/2025 from the issuer and the filing states payment on 09/04/2025 in cash. The filing lists total shares outstanding of 239,562,995 for the issuer. The filer also disclosed two prior sales by Christopher Ryan in August 2025 totaling 86,463 shares for gross proceeds of $107,381.00 (42,499 shares on 08/05/2025 for $52,299.00 and 43,964 shares on 08/01/2025 for $55,082.00). The notice includes the standard attestation that the seller is not aware of undisclosed material adverse information.

Gevo, Inc. Form 144 notice: An affiliated person proposes to sell 1,642 shares of Gevo common stock through Stifel Nicolaus on 09/04/2025 with an aggregate market value of $2,183.00. The securities were acquired as Restricted Stock Units on 09/03/2025 from the issuer and payment is listed as cash on 09/04/2025. The filer discloses two prior sales by the same person during August 2025: 116,060 shares on 08/05/2025 for $142,823.00 and 120,304 shares on 08/01/2025 for $150,728.88. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Gevo, Inc. Form 144 summary: An insider filing discloses a proposed sale of 1,530 shares of Gevo common stock through Stifel Nicolaus & Company Inc. with an aggregate market value of $2,493.00, and an approximate sale date of 09/04/2025. The filing reports the securities were acquired as restricted stock units on 09/03/2025 and payment is indicated as cash on 09/04/2025. The filing lists total shares outstanding as 239,562,995. The filer previously sold 12,370 shares on 08/05/2025 (gross proceeds $15,223.00) and 11,694 shares on 08/01/2025 (gross proceeds $14,651.00).

Gevo, Inc. Form 144 notice reports proposed sales of restricted stock converted to common stock and recent reported disposals by an insider. The filing shows 2,092 shares of Common Stock listed for proposed sale through Stifel Nicolaus on 09/04/2025 on Nasdaq with an aggregate market value of $3,411.00. The shares were acquired as Restricted Stock Units on 09/03/2025 and payment is listed as cash on 09/04/2025. The filing also discloses four prior sales by Paul Bloom in August 2025 totaling 75,228 shares for gross proceeds of $93,148.00. Several standard issuer and filer identification fields in the form are not populated in the provided content.

Agiri Oluwagbemileke Yusuf, CFO of Gevo, Inc. (GEVO), reported the sale of 57,651 shares of Gevo common stock on 08/20/2025 at a weighted average price of $1.6295 per share. After the reported disposition, the filing shows the reporting person beneficially owns 277,835 shares directly and holds an additional 18,977.57 shares indirectly through a 401(k) plan. The footnote clarifies the sale occurred in multiple transactions at prices ranging from $1.625 to $1.635 per share. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

Gevo, Inc. insider Andrew Shafer reported selling 5,000 shares of Common Stock on 08/20/2025 at a weighted average price of $1.5833 per share under a 10b5-1 trading plan adopted November 22, 2024. After the reported sale, the filing shows Mr. Shafer beneficially owns 325,620 shares directly and an additional 9,806.92 shares indirectly through the issuer's 401(k) plan. The filing also discloses that between 07/21/2025 and 08/20/2025 he disposed of 3.77 shares under the 401(k) plan to cover administrative fees. The Form 4 was signed by an attorney-in-fact on 08/21/2025.

Form 144 filed for Gevo, Inc. (GEVO) discloses a proposed sale of 57,651 shares of common stock through Stifel Nicolaus on approximately 08/20/2025 with an aggregate market value of $93,942. The filing shows the shares originated from restricted stock units granted on various dates (08/29/2022, 08/03/2023, 05/22/2024) and that prior sales by the same person occurred on 06/03/2025 (10,810 shares) and 08/05/2025 (5,738 shares) generating gross proceeds of $12,572 and $7,061 respectively. The total shares outstanding reported in the form are 239,562,995, placing this proposed sale as a small fraction of the company’s outstanding common stock. The filer certifies no undisclosed material adverse information and provides broker details for the planned transaction.

Gary W. Mize, a director of Gevo, Inc. (GEVO), executed equity transactions on 08/18/2025. He exercised stock options to acquire 224,639 shares at an exercise price of $0.67 per share, increasing his direct holdings to 479,785 shares before a subsequent sale. On the same date he sold 91,459 shares in multiple transactions at a weighted-average price of $1.6757 per share (individual sale prices ranged from $1.67 to $1.76). After the sale his direct beneficial ownership was reported as 388,326 shares. The Form 4 was signed by an attorney-in-fact on 08/19/2025. The filing discloses the option exercise date, exercise price, number of shares acquired, number sold, and the weighted-average sale price range.

Gevo, Inc. filed a Form 144 notifying the planned sale of 91,459 shares of common stock through Stifel Nicolaus & Company, Inc. on 08/18/2025 on Nasdaq. The filing shows the shares carry an aggregate market value of $153,258 and that the issuer has 241,839,083 shares outstanding. The securities were acquired by the seller on 05/23/2025 via an option exercise from the issuer, totaling 224,639 shares acquired; payment is indicated as cash with an indicated payment date of 08/18/2025. The filer reports no sales of the issuer's securities in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.